SanBio Company Limited provided consolidated earnings guidance for the fiscal year ending January 31, 2022. For the period, the company expects Operating loss of JPY 5,786 million; Ordinary loss of JPY 5,876 million; Net loss attributable to owners of parent of JPY 5,877 million and Net loss per share of JPY 113.49.